CYP2A6 overexpression in human lung cancers correlates with a high malignant status

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 53-57

  Matsuda, Yoko ^a   Yamakawa, Keiko ^a   Saoo, Kousuke ^a   Hosokawa, Kyoko ^a   Yokohira, Masanao ^a   Kuno, Toshiya ^a   Iwai, Junko ^b   Shirai, Takatoshi ^b   Obika, Kaoru ^b   Kamataki, Tetsuya ^c   Imaida, Katsumi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Takinomiya General Hospital   (Japan)

^c TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Adenocarcinoma; CYP2A6; Immunohistochemistry; Lung; Lymph node metastasis; Squamous cell carcinoma

Indexed keywords

COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; MIXED FUNCTION OXIDASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ADENOCARCINOMA; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; DISEASE COURSE; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ARYL HYDROCARBON HYDROXYLASES; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIXED FUNCTION OXYGENASES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS;

EID: 34548019756     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.53     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210, 1999.
3. Fukami T, Nakajima M, Higashi E, Yamanaka H, Sakai H, McLeod HL and Yokoi T: Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity. Drug Metab Dispos 33: 1202-1210, 2005. (Pubitemid 41043764)
4. Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T and Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis 21: 1227-1232, 2000. (Pubitemid 30389351)
5. Hughes R, Cross AJ, Pollock JR and Bingham S: Dose-dependent effect of dietary meat on endogenous colonic Nnitrosation. Carcinogenesis 22: 199-202, 2001. (Pubitemid 32098163)
6. Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y, Yokota J, Nemoto N, Sato K and Kamataki T: Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomarkers Prev 11: 890-894, 2002. (Pubitemid 35014893)
7. Ariyoshi N, Takahashi Y, Miyamoto M, Umetsu Y, Daigo S, Tateishi T, Kobayashi S, Mizorogi Y, Loriot MA, Stucker I, Beaune P, Kinoshita M and Kamataki T: Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics 10: 687-693, 2000.
8. Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Nemoto N, Sato K, Ariyoshi N and Kamataki T: CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun 261: 658-660, 1999. (Pubitemid 29408114)
9. Topcu Z, Chiba I, Fujieda M, Shibata T, Ariyoshi N, Yamazaki H, Sevgican F, Muthumala M, Kobayashi H and Kamataki T: CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis 23: 595-598, 2002. (Pubitemid 34498496)
10. Takeuchi H, Saoo K, Matsuda Y, Yokohira M, Yamakawa K, Zeng Y, Miyazaki M, Fujieda M, Kamataki T and Imaida K: Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett 234: 232-238, 2005.
11. Takeuchi H, Saoo K, Yokohira M, Ikeda M, Maeta H, Miyazaki M, Yamazaki H, Kamataki T and Imaida K: Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res 63: 7581-7583, 2003. (Pubitemid 37466676)
12. Miyazaki M, Yamazaki H, Takeuchi H, Saoo K, Yokohira M, Masumura K, Nohmi T, Funae Y, Imaida K and Kamataki T: Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis 26: 1947-1955, 2005. (Pubitemid 41631269)
13. Crawford EL, Weaver DA, DeMuth JP, Jackson CM, Khuder SA, Frampton MW, Utell MJ, Thilly WG and Willey JC: Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis 19: 1867-1871, 1998. (Pubitemid 28474654)
14. Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC and Pfeifer AM: Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 34: 914-920, 1998. (Pubitemid 28248506)
15. Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC: Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumors. IARCPress, Lyon, 2004.
16. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
17. Young ID, Ailles L, Deugau K and Kisilevsky R: Transcription of cRNA for in situ hybridization from polymerase chain reaction-amplified DNA. Lab Invest 64: 709-712, 1991.
18. Young ID, Stewart RJ, Ailles L, Mackie A and Gore J: Synthesis of digoxigenin-labeled cRNA probes for nonisotopic in situ hybridization using reverse transcription polymerase chain reaction. Biotech Histochem 68: 153-158, 1993. (Pubitemid 23180944)